New strategy to attack aggressive brain cancer shows promise
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles
Socialite Jasmine Hartin enjoys beach snuggle with electrician hunk
Socialite Jasmine Hartin has been seen enjoying a beach snuggle with her new mystery man.Ms Hartin w2024-05-21- President Xi Jinping and visiting Sri Lankan Prime Minister Dinesh Gunawardena spoke highly of the P2024-05-21
China slams Eswatini PM for visiting Taiwan
China slammed Eswatini's Prime Minister Russell Dlamini's visit to the Taiwan region, urging the Afr2024-05-21'143 people still missing' after Moscow attack
As many as 143 people are still missing after last week's attack near Moscow when gunmen sprayed con2024-05-21French sports minister calls for sanctions after Monaco player tapes over anti
PARIS (AP) — France’s sports minister has called for soccer club Monaco to be sanctioned after one o2024-05-21China to take countermeasures if U.S. imposes visa restrictions on Hong Kong officials: spokesperson
China deplores and opposes the so-called 2024 Hong Kong Policy Act Report issued by the U.S. Departm2024-05-21
atest comment